Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine

This study has been completed.

Study NCT00058799 Information provided by Baylor College of Medicine

First Received: April 11, 2003 Last Updated: July 27, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2010
Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)